Pioneering New Drug Modalities: The Future of Therapeutic Leadership

Life Sciences, Pharmaceutical, Drug Discovery & Development,
  • Wednesday, June 19, 2024 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min

Discover an informative webinar focusing on the transformative potential of multimodal drug discovery in shaping the future of therapeutic leadership. As the pharmaceutical and biotechnology landscape rapidly evolves, embracing diverse strategies and harnessing the power of new drug modalities has become essential for developing groundbreaking treatments.

In this webinar, the speakers will share insights into the diverse and dynamic world of new drug modalities, including their classification based on therapeutic mechanics and stages of development, and their projected impact on the industry. They will also discuss strategic considerations for companies navigating this dynamic field such as resource allocation, risk management and leveraging collaborative ecosystems.

They will also delve into the critical role of data-driven strategies and modern software solutions, focusing on capturing, structuring and analyzing vast amounts of data, as well as streamlining processes and facilitating decision-making. They will examine how the future of drug discovery is being shaped by technological advancements and scientific breakthroughs, particularly through artificial intelligence (AI), machine learning (ML) and transformative collaborative ecosystems.

They will also highlight how Revvity Signals’ cutting-edge solutions, such as the Signals Research Suite, can support and accelerate multimodal drug discovery efforts by providing tools that facilitate collaboration, streamline data management and empower scientists.

Register for this webinar today to gain insights into the impact of new drug modalities, strategic considerations for navigating the drug discovery field and the role of data-driven strategies.


Zev Wisotsky, Revvity Signals

Zev Wisotsky, Director of Drug Discovery Informatics, Revvity Signals

Zev Wisotsky is Director of Drug Discovery Informatics at Revvity Signals. His scientific training and research background includes neuroscience, biochemistry, molecular biology and drug discovery. He has spent over eight years in software in go-to-market teams across industries with a heavy focus on biopharma/biotech R&D.

Message Presenter

Who Should Attend?

This webinar is intended for professionals in the pharmaceutical and biotechnology industries, including but not limited to:

  • Drug Discovery Scientists
  • Research and Development Managers, Team Leads, Directors
  • Therapeutic Area Leaders, VPs
  • Business Development Executives
  • Data Scientists and Bioinformaticians

What You Will Learn

Attendees will learn about:

  • The diverse landscape of new drug modalities and their transformative potential
  • Strategic approaches for navigating the risks and opportunities in multimodal drug discovery
  • The importance of collaborative ecosystems and data-driven strategies in driving innovation
  • How Revvity Signals’ solutions can support and accelerate multimodal drug discovery efforts

Xtalks Partner

Revvity Signals Software

Revvity Signals Software, Inc. is a leading provider of innovative software solutions for the pharmaceutical and biotechnology industries. Revvity Signals Software is a division of Revvity, Inc. a dedicated team of about 11,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the well-being and longevity of people globally. Revvity reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is part of the SAP 500 index.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account